291 related articles for article (PubMed ID: 17583466)
1. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis.
Burch F; Fishman R; Messina N; Corser B; Radulescu F; Sarbu A; Craciun-Nicodin MM; Chiriac R; Beaulieu A; Rodrigues J; Beignot-Devalmont P; Duplan A; Robertson S; Fortier L; Bouchard S
J Pain Symptom Manage; 2007 Sep; 34(3):328-38. PubMed ID: 17583466
[TBL] [Abstract][Full Text] [Related]
2. Women with pain due to osteoarthritis: the efficacy and safety of a once-daily formulation of tramadol.
Kean WF; Bouchard S; Roderich Gossen E
Pain Med; 2009 Sep; 10(6):1001-11. PubMed ID: 19671089
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD).
Fishman RL; Kistler CJ; Ellerbusch MT; Aparicio RT; Swami SS; Shirley ME; Jain AK; Fortier L; Robertson S; Bouchard S
J Opioid Manag; 2007; 3(5):273-80. PubMed ID: 18181382
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
Babul N; Noveck R; Chipman H; Roth SH; Gana T; Albert K
J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085
[TBL] [Abstract][Full Text] [Related]
6. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
7. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
Choi CB; Song JS; Kang YM; Suh CH; Lee J; Choe JY; Lee CK; Shim SC; Chung WT; Song GG; Kim HA; Ji JD; Nam EJ; Park SH; Hong YH; Sheen DH; Lim MK; Seo YI; Sung YK; Kim TH; Lee JT; Bae SC
Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis.
Roth SH
J Rheumatol; 1998 Jul; 25(7):1358-63. PubMed ID: 9676769
[TBL] [Abstract][Full Text] [Related]
9. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
Schnitzer TJ; Kamin M; Olson WH
Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
[TBL] [Abstract][Full Text] [Related]
10. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tramadol in treatment of chronic low back pain.
Schnitzer TJ; Gray WL; Paster RZ; Kamin M
J Rheumatol; 2000 Mar; 27(3):772-8. PubMed ID: 10743823
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
Beaulieu AD; Peloso P; Bensen W; Clark AJ; Watson CP; Gardner-Nix J; Thomson G; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC
Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
[TBL] [Abstract][Full Text] [Related]
13. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
[TBL] [Abstract][Full Text] [Related]
15. Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain.
Pascual ML; Fleming RR; Gana TJ; Vorsanger GJ
Curr Med Res Opin; 2007 Oct; 23(10):2531-42. PubMed ID: 17825129
[TBL] [Abstract][Full Text] [Related]
16. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
Alemdar M; Pekdemir M; Selekler HM
Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
[TBL] [Abstract][Full Text] [Related]
17. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis.
Adler L; McDonald C; O'Brien C; Wilson M
J Rheumatol; 2002 Oct; 29(10):2196-9. PubMed ID: 12375333
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
19. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial.
Matsumoto AK; Babul N; Ahdieh H
Pain Med; 2005; 6(5):357-66. PubMed ID: 16266356
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study.
Perrot S; Krause D; Crozes P; Naïm C;
Clin Ther; 2006 Oct; 28(10):1592-606. PubMed ID: 17157115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
